A roundup of this morning’s news: B.C. biotech in spotlight after Pfizer-BioNTech vaccine approved. Plus: Post-COVID recovery predicted to be greener
B.C. biotech in the spotlight after Health Canada approves Pfizer-BioNTech vaccine
Vancouver-based Acuitas Therapeutics played key role in vaccine's development.
Vaccine delay threatens health of B.C. economy
But competitive advantage for some industries might not be lost even if COVID-19 vaccine is slow to arrive in Canada.
Post-pandemic recovery predicted to be greener
COVID-19 opened door to accelerate decarbonisation.
Parallel Domain eyes Vancouver expansion in pursuit of computer vision tech
Expansion plans for tech company’s Vancouver office come amid US$11m raise
Harbour Air commits to net zero by 2040
Harbour Air first Canadian company to sign climate pledge spearheaded by Amazon
COVID-19 health privacy exemptions continue to be scrutinized
Laws relaxed at pandemic start now extended into 2021
Vancouver council rejects VPD budget request by $5.7 million
Council approved property tax hike of 5% on city-wide $1.597 billion operating budget
